Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01524198Phase 3Completed
Phase 3, randomised, double-blind trial in asthma comparing Budesonide Arm with Placebo Arm (2 arms). Primary endpoint: Patients Hospitalization Rate at 4 hours. Started Nov 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01524198.